| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.07 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.27 | 0.07 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |